Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer

NCT04750239 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to business priorities

Conditions

SCLC

Interventions

DRUG: Nivatrotamab

Sponsor

Y-mAbs Therapeutics